Search results for "biopharma 4.0"
Article
Tapas & TECH Talks: Panel Discussion with Cytiva/IQVIA
Click here to register now >>
When developing a new therapy, it is more important than ever to have the future in mind from the outset. The choices you make at each step can set you up for …
Article
Highlights from the 5th International HTPD Conference, Part 3: Smart Process Development and a Look into the Future
Click here to read the full article >>
The high-throughput process development (HTPD) conference series is the key international forum for the presentation and discussion of topics relevant t…
Article
Mechanistic Modeling: Current Advantages and Future Opportunities in Biopharmaceutical Process Development
Mechanistic modeling is considered a part of smart process development, which is a collection of approaches to get better process outcomes and speed up process development.
This week, Bioproce…
Article
Process Development Webinar Library
Time to experiment, time to clinic, and time to market are becoming even more important for developers and manufacturers of biopharmaceuticals.
Cytiva’s library of on-demand webinars are de…
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.
By: Pranav Vengsarkar and Nandu Deorkar
I…
Article
Lentiviral Vector Upstream Process in Single-use Bioreactors
Click here to read the article >>
Lentiviruses exhibit many desirable properties as gene transfer vehicles, such as high transduction efficiencies, ability to infect both dividing and nondivi…
Article
Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips
Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-house or work with a contract devel…
Article
Improving Lentiviral Vector Downstream Processing Workflows
Lentiviral vectors (LVV) are a common vehicle to deliver genetic material in chimeric antigen receptor (CAR) T-cell therapy and gene therapy applications. Production methods have been developed by a…
Article
Biomanufacturing: Demand for Continuous Bioprocessing Increasing
Biomanufacturing: Demand for Continuous Bioprocessing Increasing
But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options. …
Article
Do You Need Access to a Bioprocess Lab to Test Your Technical or Digital Innovation?
Welcome to Testa Challenge!
In the Testa Challenge, we invite projects and companies from the technology, digital, and data segments to integrate, test, and verify their innovation with…